能发育为活产的囊胚其发育阶段与形态与子代性别相关而与其它产科结局无关:一项多中心队列研究
该多中心历史性队列研究纳入2014-2018年16家机构中单囊胚移植后单胎活产的4842名女性,分析囊胚移植日、发育阶段和形态与早产、出生体重、出生身长及子代性别的关系。结果显示囊胚发育阶段高评分和滋养外胚层高评分与子代性别显著相关,而与早产和出生体重无显著关联,与出生身长有统计学显著但幅度很小的关联。
要点
- 囊胚发育阶段评分为5分者相比3分者,子代为男孩的概率增加34%(OR 1.34,95%CI 1.09-1.64)。
- 滋养外胚层评分为B的囊胚相比评分为A者,子代为男孩的概率降低31%(OR 0.69,95%CI 0.60-0.80)。
- 囊胚评估评分与早产(8.3%)或出生体重(平均3461.7 g)无统计学显著关联。
核心结论
- 囊胚发育阶段高评分和滋养外胚层高评分与子代性别显著相关,而未观察到与其它产科结局的关联。
- 囊胚评估评分本身不会带来早产风险或影响出生体重和出生身长,临床医生和患者可对此放心。
研究设计与样本
- 多中心历史性队列研究,基于16家私立和大学附属临床服务与研究机构的数据。
- 2014-2018年共识别7246名接受新鲜单囊胚移植或冻融单囊胚移植后单胎妊娠的女性, linkage至丹麦医学出生登记后最终纳入4842名活产女性。
- 排除接受植入前遗传学检测和捐赠配子的周期。
- 分析调整了女性年龄(n=4842)、BMI(n=4302)、吸烟(n=4290)、产次(n=4365)、不孕诊断(n=4765)、治疗类型(n=4842)和中心(n=4842),部分分析额外纳入孕周(n=4368)和子代性别(n=4833)。
主要发现
- 囊胚评估评分(移植日、发育阶段、滋养外胚层、内细胞团)与早产(8.3%)或出生体重(平均3461.7 g)之间未发现统计学显著关联。
- 滋养外胚层评分为C的囊胚与评分为A的囊胚相比,出生身长(平均51.6 cm)的调整后关联具有统计学显著性,调整后平均差为0.4 cm(95%CI:0.02;0.77)。
- 移植发育阶段评分为5分的囊胚相比评分为3分的囊胚,子代为男孩的概率增加34%(OR 1.34,95%CI:1.09;1.64)。
- 滋养外胚层评分为B的囊胚相比评分为A的囊胚,子代为男孩的概率降低31%(OR 0.69,95%CI:0.60;0.80)。
临床怎么用
- 辅助生殖技术中的囊胚选择似乎不会对产科结局产生负面影响。
- 临床医生和患者可放心,所选囊胚的评估评分本身不会带来早产风险或影响出生体重和出生身长。
局限性
- 原文指出可能仍存在一些残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are transfer day, developmental stage and morphology of the competent blastocyst in pregnancies leading to live birth associated with preterm birth, birthweight, length at birth and sex of the child? SUMMARY ANSWER: A high score in blastocyst developmental stage and in trophectoderm (TE) showed a significant association with the sex of the child, while no other associations with obstetric outcomes were observed. WHAT IS KNOWN ALREADY: The association between blastocyst assessment scores and obstetric outcomes have been reported in small single-center studies and the results are conflicting. STUDY DESIGN, SIZE, DURATION: Multicenter historical cohort study based on exposure data (transfer day (blastocyst developmental stage reached by Day 5 or Day 6)) blastocyst developmental stage (1-6) and morphology (TE and inner cell mass (ICM): A, B, C)) and outcome data (preterm birth, birthweight, length at birth, and sex of the child) from women undergoing single blastocyst transfer resulting in a singleton pregnancy and live birth. PARTICIPANTS/MATERIALS, SETTING, METHODS: Data from 16 private and university-based facilities for clinical services and research were used. A total of 7246 women, who in 2014-2018 underwent fresh-embryo transfer with a single blastocyst or frozen-thawed embryo transfer (FET) with a single blastocyst resulting in a singleton pregnancy were identified. Linking to the Danish Medical Birth Registry resulted in a total of 4842 women with a live birth being included. Cycles with pre-implantation genetic testing and donated gametes were excluded. The analyses were adjusted for female age (n = 4842), female BMI (n = 4302), female smoking (n = 4290), parity (n = 4365), infertility diagnosis (n = 4765), type of treatment (n = 4842) and center (n = 4842); some analyses additionally included gestational age (n = 4368) and sex of the child (n = 4833). MAIN RESULTS AND THE ROLE OF CHANCE: No statistically significant associations between blastocyst assessment scores (transfer day, developmental stage, TE, ICM) and preterm birth (8.3%) or birthweight (mean 3461.7 g) were found. The adjusted association between blastocysts with a TE score of C and a TE score of A and length at birth (mean 51.6 cm) were statistically significant (adjusted mean difference 0.4 cm (95% CI: 0.02; 0.77)). Blastocysts transferred with developmental stage score 5 compared to blastocysts transferred with score 3 had a 34% increased probability of being a boy (odds ratio (OR) 1.34 (95% CI: 1.09; 1.64). Further, TE score B blastocysts compared to TE score A blastocysts had a 31% reduced probability of being a boy (OR 0.69 (95% CI: 0.60; 0.80)). LIMITATIONS, REASONS FOR CAUTION: It is possible that some residual confounding remains. WIDER IMPLICATIONS OF THE FINDINGS: Blastocyst selection during ART does not appear to introduce any negative effects on obstetric outcome. Therefore, clinicians and patients can be reassured that the assessment scores of the selected blastocyst will not in themselves pose a risk of preterm birth or affect birthweight and the length at birth. STUDY FUNDING/COMPETING INTEREST(S): Unrestricted grant from Gedeon Richter Nordics AB, Sweden. None of the authors have any competing interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Borgstrøm MB, Kesmodel US, Klausen TW, et al. Developmental stage and morphology of the competent blastocyst are associated with sex of the child but not with other obstetric outcomes: a multicenter cohort study. Hum Reprod. 2021. PMID: 34986219. doi:10.1093/humrep/deab242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。